Browse by People

Butterworth, Michael, Pettitt, Andrew, Varadarajan, Shankar ORCID: 0000-0002-8827-6567 and Cohen, Gerald M (2016) BH3 profiling and a toolkit of BH3-mimetic drugs predict anti-apoptotic dependence of cancer cells. BRITISH JOURNAL OF CANCER, 114 (6). pp. 638-641.

Keadsanti, S (2018) THE CHEMOKINE REGULATION OF BRUTON’S TYROSINE KINASE IN ACUTE MYELOID LEUKAEMIA. PhD thesis, University of Liverpool.

Collapse authors list.
Munir, Talha, Cairns, David A, Bloor, Adrian, Allsup, David, Cwynarski, Kate, Pettitt, Andrew ORCID: 0000-0002-0907-8950, Paneesha, Shankara, Fox, Christopher P, Eyre, Toby A, Forconi, Francesco ORCID: 0000-0002-2211-1831 et al (show 23 more authors) , Elmusharaf, Nagah, Kennedy, Ben, Gribben, John, Pemberton, Nicholas, Sheehy, Oonagh, Preston, Gavin, Schuh, Anna, Walewska, Renata, Duley, Lelia ORCID: 0000-0001-6721-5178, Howard, Dena, Hockaday, Anna, Jackson, Sharon, Greatorex, Natasha, Girvan, Sean, Bell, Sue, Brown, Julia M, Webster, Nichola, Dalal, Surita, de Tute, Ruth, Rawstron, Andrew, Patten, Piers EM ORCID: 0000-0003-3320-3034, Hillmen, Peter and National Cancer Research Institute Chronic Lymphocytic Leukemia , (2024) Chronic Lymphocytic Leukemia Therapy Guided by Measurable Residual Disease. The New England journal of medicine, 390 (4). pp. 326-337.

Popa, Mariana, Rousseau, Nikki, Cherry, Mary G, Jenkins, Isobel, Cloke, Jane ORCID: 0000-0001-6332-9186, Pettitt, Andrew, Jenkinson, Michael D ORCID: 0000-0003-4587-2139, Young, Bridget and Sherratt, Frances ORCID: 0000-0003-4147-9305 (2022) Comparing trial communication between patients from the most and least socio-economically disadvantaged backgrounds: qualitative findings from three studies embedded in cancer-related trials. In: 6th International Clinical Trials Methodology Conference, 2022-10-3 - 2022-10-6, Harrogate, UK.

Mohammad, Ishaque ORCID: 0000-0001-7913-8026, Lin, Ke, Oates, Melanie, Khan, Umair ORCID: 0000-0002-9470-3481, Burger, Jan, Pettitt, Andrew and Zhuang, Jianguo ORCID: 0000-0003-3245-0789 (2021) Development of a cell-line model to mimic the pro-survival effect of nurse-like cells in chronic lymphocytic leukemia. Leukemia and Lymphoma, 62 (1). pp. 45-57.

Milani, M (2019) Exploring the therapeutic potential and cellular mechanisms of BH3 mimetic-mediated apoptosis in cancer. PhD thesis, University of Liverpool.

Till, Kathy ORCID: 0000-0002-3172-5771, Pettitt, Andrew and Slupsky, Joseph ORCID: 0000-0002-7410-9004 (2015) Expression of functional sphingosine-1 phosphate receptor-1 is reduced by B cell receptor signaling and increased by inhibition of PI3 kinase δ but not SYK or BTK in chronic lymphocytic leukaemia cells. The Journal of Immunology, 194. (In Press)

Collapse authors list.
Lin, Wei-Yu, Fordham, Sarah E, Sunter, Nicola, Elstob, Claire, Rahman, Thahira, Willmore, Elaine, Shepherd, Colin, Strathdee, Gordon, Mainou-Fowler, Tryfonia, Piddock, Rachel et al (show 26 more authors) , Mearns, Hannah, Barrow, Timothy, Houlston, Richard S, Marr, Helen, Wallis, Jonathan, Summerfield, Geoffrey, Marshall, Scott, Pettitt, Andrew, Pepper, Christopher, Fegan, Christopher, Forconi, Francesco, Dyer, Martin JS, Jayne, Sandrine, Sellors, April, Schuh, Anna, Robbe, Pauline, Oscier, David, Bailey, James, Rais, Syed, Bentley, Alison, Cawkwell, Lynn, Evans, Paul, Hillmen, Peter, Pratt, Guy, Allsup, David J and Allan, James M (2021) Genome-wide association study identifies risk loci for progressive chronic lymphocytic leukemia. NATURE COMMUNICATIONS, 12 (1). 665-.

Collapse authors list.
Bhogal, Talvinder ORCID: 0000-0003-3297-9957, Khan, Umair T ORCID: 0000-0002-9470-3481, Lee, Rebecca, Stockdale, Alexander ORCID: 0000-0002-5828-3328, Hesford, Christian, Potti-Dhananjaya, Vaishnav, Jathanna, Avith, Rahman, Shaun, Tivey, Ann, Shotton, Rohan et al (show 13 more authors) , Sundar, Ram, Valerio, Christopher, Norouzi, Amir, Walker, Philip, Suckling, Ruth, Armstrong, Anne, Brearton, Gillian, Pettitt, Andrew, Kalakonda, Nagesh ORCID: 0000-0002-5300-1360, Palmer, Daniel H ORCID: 0000-0002-7147-5703, Jackson, Richard, Turtle, Lance ORCID: 0000-0002-0778-1693 and Palmieri, Carlo ORCID: 0000-0001-9496-2718 (2021) Haematological malignancy and nosocomial transmission are associated with an increased risk of death from COVID-19: results of a multi-center UK cohort. Leukemia & lymphoma, 62 (7). pp. 1-16.

Collapse authors list.
Hillmen, Peter, Rawstron, Andy C, Brock, Kristian, Muñoz-Vicente, Samuel, Yates, Francesca J, Bishop, Rebecca, Boucher, Rebecca, MacDonald, Donald, Fegan, Christopher, McCaig, Alison et al (show 9 more authors) , Schuh, Anna, Pettitt, Andrew, Gribben, John G, Patten, Piers EM, Devereux, Stephen, Bloor, Adrian, Fox, Christopher P, Forconi, Francesco and Munir, Talha (2019) Ibrutinib Plus Venetoclax in Relapsed/Refractory Chronic Lymphocytic Leukemia: The CLARITY Study. Journal of Clinical Oncology, 37 (30). pp. 2722-2730.

Khan, Umair ORCID: 0000-0002-9470-3481 (2022) Investigation of variable therapy outcomes in chronic lymphocytic leukaemia using a proteomics approach. PhD thesis, University of Liverpool.

Collapse authors list.
Eagle, Gina, Zhuang, Jack ORCID: 0000-0003-3245-0789, Oates, Melanie, Kitteringham, Neil, Herbert, John, Falciani, Francesco ORCID: 0000-0003-1432-2871, Pettitt, Andrew, Park, Kevin, Jenkins, Rosalind, Devereux, Stephen et al (show 2 more authors) , Schuh, Anna and Hillmen, Peter (2017) Linking genotype to clinical phenotype through proteomic analysis of CLL trial samples. .

Nwosu, Amara Callistus ORCID: 0000-0003-0014-3741, Morris, Lauren, Mayland, Catriona ORCID: 0000-0002-1440-9953, Mason, Stephen ORCID: 0000-0002-4020-6869, Pettitt, Andrew and Ellershaw, John ORCID: 0000-0001-9789-3180 (2016) Longitudinal bioimpedance assessments to evaluate hydration in POEMS syndrome. BMJ SUPPORTIVE & PALLIATIVE CARE, 6 (3). pp. 369-372.

Mohammad, Ishaque ORCID: 0000-0001-7913-8026 (2021) Molecular Characterisation of Interaction between Nurse-like cells and Chronic Lymphocytic Leukaemia cells. PhD thesis, University of Liverpool.

Su, Chang (2021) Proteomic study of the CD40 stimulation-induced pro-survival effect on chronic lymphocytic leukaemia cells. PhD thesis, University of Liverpool.

Almalki, Waad (2021) ROLE OF TRAF FAMILY OF PROTEINS IN MEDIATING CD40 STIMULATION-INDUCED DRUG RESISTANCE IN CHRONIC LYMPHOCYTIC LEUKAEMIA CELLS. PhD thesis, University of Liverpool.

Zhuang, Jack ORCID: 0000-0003-3245-0789, Luckett, Teifion, Cheng, Xiang, Oates, Melanie, Varadarajan, Shankar ORCID: 0000-0002-8827-6567 and Pettitt, Andrew (2020) Resistance to venetoclax-induced apoptosis of CLL cells due to CD40 stimulation can be reversed by BCL-XL inhibition. .

Collapse authors list.
Khan, Umair Tahir ORCID: 0000-0002-9470-3481, Kelly, Michael, Dodd, James, Fergiani, Sammy, Hammer, Barbara, Smith, Jeffrey, Arumainathan, Arvind, Atherton, Mark, Carter, Anthony, Racu-Amoasii, Igor et al (show 3 more authors) , Kalakonda, Nagesh ORCID: 0000-0002-5300-1360, Pettitt, Andrew and Menon, Geetha (2021) Role of MYC and BCL2 expression in a cohort of 43 patients with DLBCL: a retrospective study. JOURNAL OF CLINICAL PATHOLOGY, 74 (12). pp. 816-818.

Tayeb, FJ (2018) A Study of Genomic Instability in Chronic Lymphocytic Leukaemia (CLL). PhD thesis, University of Liverpool.

Collapse authors list.
Eagle, Gina ORCID: 0000-0002-7381-2355, Zhuang, Jack ORCID: 0000-0003-3245-0789, Jenkins, Roz, Till, Kathy ORCID: 0000-0002-3172-5771, Jithesh, Puthen, Lin, Ke, Johnson, Gillian, Oates, Melanie, Park, Kevin ORCID: 0000-0001-8384-824X, Kitteringham, Neil et al (show 1 more authors) and Pettitt, Andrew (2015) Total Proteome Analysis Identifies Migration Defects as a Major Pathogenetic Factor in Immunoglobulin Heavy Chain Variable Region (IGHV)-unmutated Chronic Lymphocytic Leukemia. Molecular and Cellular Proteomics, 14 (4). pp. 933-945.

Mohammad, Ishaque Sayeed ORCID: 0000-0001-7913-8026, Zhuang, Jack ORCID: 0000-0003-3245-0789, Pettitt, Andrew, Oates, Melanie and Lin, Ke (2017) Use of differentiated THP. 1 cells to mimic nurse-like cells for its pro-survival effect on chronic lymphocytic leukaemia cells. In: iwCLL2017, 2017-5-12 - 2017-5-15, New York City, USA.

Collapse authors list.
Offner, Fritz, Robak, Tadeusz, Janssens, Ann, Babu, K Govind, Kloczko, Janusz, Grosicki, Sebastian, Mayer, Jiri, Panagiotidis, Panagiotis, Schuh, Anna, Pettitt, Andrew et al (show 5 more authors) , Montillo, Marco, Werner, Olena, Vincent, Ghislaine, Khanna, Sadhvi and Hillmen, Peter (2020) A five-year follow-up of untreated patients with chronic lymphocytic leukaemia treated with ofatumumab and chlorambucil: final analysis of the Complement 1 phase 3 trial. BRITISH JOURNAL OF HAEMATOLOGY, 190 (5). pp. 736-740.

Alharthi, Afaf, Beck, Daniel, Howard, Dena R, Hillmen, Peter, Oates, Melanie, Pettitt, Andrew and Wagner, Simon D ORCID: 0000-0002-8914-0370 (2018) An increased fraction of circulating miR-363 and miR-16 is particle bound in patients with chronic lymphocytic leukaemia as compared to normal subjects. BMC research notes, 11 (1). 280-.

Collapse authors list.
Pratt, Guy, Yap, Christina, Oldreive, Ceri, Slade, Daniel, Bishop, Rebecca, Griffiths, Mike, Dyer, Martin JS, Fegan, Chris, Oscier, David, Pettitt, Andrew et al (show 9 more authors) , Matutes, Estella, Devereux, Stephen, Allsup, David, Bloor, Adrian, Hillmen, Peter, Follows, George, Rule, Simon, Moss, Paul and Stankovic, Tatjana (2018) A multi-centre phase I trial of the PARP inhibitor olaparib in patients with relapsed chronic lymphocytic leukaemia, T-prolymphocytic leukaemia or mantle cell lymphoma. BRITISH JOURNAL OF HAEMATOLOGY, 182 (3). pp. 429-433.

Collapse authors list.
Eyre, Toby A, Hildyard, Catherine, Hamblin, Angela, Ali, Ayesha S, Houlton, Aimee, Hopkins, Louise, Royston, Daniel, Linton, Kim M, Pettitt, Andrew, Rule, Simon et al (show 11 more authors) , Cwynarski, Kate, Barrington, Sally F, Warbey, Victoria, Wrench, David, Barrans, Sharon, Hirst, Caroline S, Panchal, Anesh, Roudier, Martine P, Harrington, Elizabeth A, Davies, Andrew and Collins, Graham P (2019) A phase II study to assess the safety and efficacy of the dual mTORC1/2 inhibitor vistusertib in relapsed, refractory DLBCL. HEMATOLOGICAL ONCOLOGY, 37 (4). pp. 352-359.